On 13 January 2012, BIOTRONIK, a leading manufacturer of high quality products for vascular intervention, implantable cardiac pacemaker and defibrillators and the pioneer of wireless remote monitoring technology, announced the opening of its new regional headquarters in Singapore, a move that emphasizes the continuous commitment of the company to building a strong leadership position in Asia Pacific. 

BIOTRONIK will form a growing cluster of cardiovascular medical device companies who have set up strategic functions to drive regional growth from Singapore. These include other German medical technology companies such as Siemens Medical Instruments and Qiagen.

"BIOTRONIK is one of the leading cardiovascular companies in the world and we are proud BIOTRONIK has chosen Singapore to be its Asia Pacific headquarters. Singapore, with its strong regional connectivity and talent base, is well positioned as the strategic base to help companies access, manage, and grow the diverse Asia Pacific market," said Mr. Kevin Lai, Deputy Director, Biomedical Sciences, Singapore Economic Development Board.

BIOTRONIK is a global enterprise that has achieved consistent double-digit growth in revenue during the last seven years, as well having doubled its job opportunities for employees. In Asia Pacific alone, BIOTRONIK has tripled its revenue over the last five years and now employs more than 250 representatives.